Schonfeld G, Bradshaw R A, Chen J
J Biol Chem. 1976 Jul 10;251(13):3921-6.
Only 5 to 10% of the apolipoprotein A-I (ApoA-I) of intact high density lipoprotein (HDL) is detectable by radioimmunoassay. In addition, when isolated ApoA-I is recombined with lipids in vitro, its immunologic reactivity is decreased by 30 to 95%. Thus, ApoA-I is less reactive immunologically in the presence of lipids. Our aim was to ascertain whether the COOH- or NH2-terminal regions of ApoA-I were equally reactive in intact HDL2. CNBr fragments of ApoA-I were produced by the method of Baker et al. (Baker, H.N., Jackson, R.L., and Gotto, A.M. (1973) Biochemistry 12, 3866-3871) and iodinated with lactoperoxidase. Double-antibody radioimmunoassays were set up using anti ApoA-I antisera and 125I-CNBr I (COOH-terminal region) or 125I-CNBr II (NH2-terminal). Both labels were bound by the antisera. Affinity columns were prepared by binding CNBr I or CNBr II to Sepharose 4B. Antibodies specific against CNBr I or CNBr II were isolated by means of these columns, suggesting that ApoA-I had at least two antigenic sites. In other assays using labeled fragments and anti ApoA-I antisera, 125I-CNBr I was displaced by CNBr I, ApoA-I , and HDL2 but not CNBr II. Conversely, 125I-CNBr II was displaced by CNBr II, ApoA-I, and HDL2 but not by CNBr I. Thus the assays were region-specific. The reactivities of isolated ApoA-I and the ApoA-I in intact HDL2-ApoA-I) were compared in these assays. On a molar basis, HDL2-ApoA-I was consistently more reactive (2- to 5-fold) in the 125I-CNBr I than in the 125I-CNBr II assays. The findings suggest (a) that the two terminal regions of ApoA-I are immunologically distinct, (b) that the two regions can be assayed independently of each other in intact HDL2, and (c) that the COOH-terminal region is more reactive immunologically than is the NH2-terminal. The results are compatible with a more "exposed" position for the COOH-terminal region on the surface of HDL2.
完整的高密度脂蛋白(HDL)中只有5%至10%的载脂蛋白A-I(ApoA-I)可通过放射免疫测定法检测到。此外,当分离出的ApoA-I在体外与脂质重新组合时,其免疫反应性会降低30%至95%。因此,在脂质存在的情况下,ApoA-I的免疫反应性较低。我们的目的是确定在完整的HDL2中,ApoA-I的COOH端或NH2端区域的免疫反应性是否相同。ApoA-I的溴化氰片段采用Baker等人(Baker, H.N., Jackson, R.L., and Gotto, A.M. (1973) Biochemistry 12, 3866 - 3871)的方法制备,并用过氧化物酶碘化。使用抗ApoA-I抗血清和125I-溴化氰I(COOH端区域)或125I-溴化氰II(NH2端)建立双抗体放射免疫测定法。两种标记物均与抗血清结合。通过将溴化氰I或溴化氰II与琼脂糖4B结合制备亲和柱。通过这些柱子分离出针对溴化氰I或溴化氰II的特异性抗体,这表明ApoA-I至少有两个抗原位点。在其他使用标记片段和抗ApoA-I抗血清的测定中,125I-溴化氰I被溴化氰I、ApoA-I和HDL2取代,但不被溴化氰II取代。相反,125I-溴化氰II被溴化氰II、ApoA-I和HDL2取代,但不被溴化氰I取代。因此,这些测定是区域特异性的。在这些测定中比较了分离出的ApoA-I和完整HDL2-ApoA-I中的ApoA-I的反应性。以摩尔为基础,在125I-溴化氰I测定中,HDL2-ApoA-I的反应性始终比在125I-溴化氰II测定中高(2至5倍)。这些发现表明:(a)ApoA-I的两个末端区域在免疫方面是不同的;(b)在完整的HDL2中,这两个区域可以相互独立地进行测定;(c)COOH端区域的免疫反应性比NH2端区域更高。这些结果与HDL2表面COOH端区域处于更“暴露”的位置相一致。